Accurate Wealth Management LLC Has $418,000 Stake in Danaher Co. (NYSE:DHR)

Accurate Wealth Management LLC grew its position in shares of Danaher Co. (NYSE:DHR) by 14.9% in the 4th quarter, Holdings Channel reports. The institutional investor owned 1,778 shares of the conglomerate’s stock after acquiring an additional 230 shares during the period. Accurate Wealth Management LLC’s holdings in Danaher were worth $418,000 as of its most recent SEC filing.

Several other institutional investors have also made changes to their positions in DHR. Fort Pitt Capital Group LLC raised its stake in shares of Danaher by 3.2% in the 3rd quarter. Fort Pitt Capital Group LLC now owns 238,092 shares of the conglomerate’s stock valued at $66,194,000 after acquiring an additional 7,421 shares in the last quarter. Good Life Advisors LLC bought a new position in shares of Danaher in the 3rd quarter valued at approximately $217,000. ORG Partners LLC raised its stake in shares of Danaher by 1,212.8% in the 4th quarter. ORG Partners LLC now owns 2,770 shares of the conglomerate’s stock valued at $636,000 after acquiring an additional 2,559 shares in the last quarter. Harvest Portfolios Group Inc. raised its stake in shares of Danaher by 1.2% in the 3rd quarter. Harvest Portfolios Group Inc. now owns 202,263 shares of the conglomerate’s stock valued at $56,233,000 after acquiring an additional 2,465 shares in the last quarter. Finally, Stifel Financial Corp raised its stake in shares of Danaher by 1.3% in the 3rd quarter. Stifel Financial Corp now owns 847,348 shares of the conglomerate’s stock valued at $235,583,000 after acquiring an additional 11,216 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Price Performance

Shares of DHR stock opened at $237.78 on Thursday. The stock’s fifty day simple moving average is $235.27 and its 200 day simple moving average is $253.56. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.37 and a quick ratio of 1.01. The firm has a market cap of $171.74 billion, a price-to-earnings ratio of 45.38, a P/E/G ratio of 4.32 and a beta of 0.83. Danaher Co. has a one year low of $222.53 and a one year high of $281.70.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, beating the consensus estimate of $1.57 by $0.14. The business had revenue of $5.80 billion for the quarter, compared to analyst estimates of $5.59 billion. Danaher had a return on equity of 10.62% and a net margin of 16.39%. Danaher’s quarterly revenue was up 3.1% on a year-over-year basis. During the same quarter in the previous year, the firm earned $2.02 EPS. On average, analysts expect that Danaher Co. will post 7.5 earnings per share for the current fiscal year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Friday, December 27th will be paid a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a yield of 0.45%. The ex-dividend date of this dividend is Friday, December 27th. Danaher’s dividend payout ratio is currently 20.61%.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on DHR shares. Royal Bank of Canada cut their price objective on Danaher from $333.00 to $311.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 23rd. StockNews.com downgraded Danaher from a “buy” rating to a “hold” rating in a research report on Saturday, December 14th. Citigroup dropped their price target on Danaher from $305.00 to $285.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Robert W. Baird dropped their price target on Danaher from $278.00 to $277.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 23rd. Finally, Raymond James dropped their price target on Danaher from $310.00 to $300.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 23rd. Six analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $286.80.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.